pharmaphorum November 18, 2021
Phil Taylor

A virtual reality system developed by AppliedVR that has been shown in trials to help reduce chronic lower back pain has been approved by the FDA as a prescription digital therapeutic (DTx).

The EaseVRx system uses a VR headset and controller to deliver a course of 56 cognitive behavioural therapy (CBT) sessions – each between 2 and 16 minutes long – that are intended to address the physiological symptoms of pain over an eight-week period.

The system includes “breathing amplifier” attached to the headset that helps the user carry out deep breathing exercises during the sessions, which aim to tackle pain through techniques including deep relaxation, attention-shifting, mindfulness and healthy movement.

The aim is to increase chronic lower back pain...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Metaverse/VR, Technology
Journey Into Virtual Reality Eases Cancer Pain
New virtual reality experience improves student mental health
VR off a smartphone? Tech breakthrough could allow seniors to do away with clunky headsets
Virtual sessions lessen seniors’ cancer pain, study finds
Immersive virtual reality beneficial for pain relief in cancer

Share This Article